Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Richard White honoured with Teaching Excellence Award
16 October 2025
Publications
-
Repeats mimic pathogen-associated patterns across a vast evolutionary landscape.
Journal article
Šulc P. et al, (2025), Cell genomics
-
IFNγ-induced PD-L1+MHC II+ macrophages and Tim-3+ tumor-reactive CD8+ T cells predict a response to anti-PD-1 therapy in tumor-bearing mice.
Journal article
Gabrilo J. et al, (2025), Cancer Immunol Res
-
Mechanical confinement governs phenotypic plasticity in melanoma.
Journal article
Hunter MV. et al, (2025), Nature
Seminars
